Edoxaban(1), an oral inhibitor of coagulation factor Ⅹa(FⅩa), is clinically used for the treatment of venous thromboembolism complicated by undergoing orthopaedic surgery of the lower limbs. According to retrosynthetic analysis, 1 is mainly composed of three key intermediates, namely tert-butyl [(1R,2S,5S)-2-amino-5-(dimethylcarbamoyl)-cyclohexyl]carbamate(2), 5-methyl-4,5,6,7-tetrahydrothiazolo[5,4-c]pyridine-2-carboxylic acid(3), and 2-[(5-chloropyridin-2-yl)amino]-2-oxoethyl acetate(4). Among them, the synthesis of the cis-cyclohexanediamine fragment of 2 and the thiazole ring fragment of 3 is more difficult. The paper summarizes the schemes for the synthesis of cis-cyclohexanediamine fragments by azide salts(esters), photo-extension reaction, Burgess reagent and other starting materials, and the synthesis of the thiazole ring fragment by monocyanine and sulphur, Asinger reaction, Grignard reagent and trichloroacetophenonium salts, and briefly comments on the corresponding advantages and disadvantages.
| 科 Family | 属数 Number of genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) | 属 Genus | 种数 Number of species | 占总种数比例 Percentage of total species (%) |
|---|---|---|---|---|---|---|
| 鹅膏菌科Amanitaceae | 2 | 11 | 5.26 | 鹅膏菌属 Amanita | 10 | 4.78 |
| 小菇科 Mycenaceae | 2 | 12 | 5.74 | 丝盖伞属 Inocybe | 5 | 2.39 |
| 多孔菌科 Polyporaceae | 8 | 14 | 6.70 | 蜡蘑属 Laccaria | 5 | 2.39 |
| 红菇科 Russulaceae | 3 | 23 | 11.00 | 小皮伞属 Marasmius | 6 | 2.87 |
| 小菇属 Mycena | 11 | 5.26 | ||||
| 光柄菇属 Pluteus | 5 | 2.39 | ||||
| 红菇属 Russula | 17 | 8.13 | ||||
| 栓菌属 Trametes | 5 | 2.39 |